IP Library › Granted Patent US 11,186,843
Granted Patent B2
US 11,186,843 · App. 15/120,110 · Granted Nov 30, 2021

Compositions and methods for site directed genomic modification

Inventors: Brent Brower-Toland (St. Louis, MO); Andrei Y. Kouranov (St. Louis, MO); Rosemarie Kuehn (St. Louis, MO); Richard J. Lawrence (Kirkwood, MO); Ervin D. Nagy (St. Louis, MO); Linda Rymarquis (St. Louis, MO); Veena Veena (St. Louis, MO)
Assignee: Monsanto Technology LLC
C12N15/8213C12N15/8216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,186,843
App. No.
15/120,110
Granted
Nov 30, 2021
Kind
B2
Abstract

The disclosure provides novel corn, tomato, and soybean U6, U3, U2, U5, and 7SL snRNA promoters which are useful for CRISPR/Cas-mediated targeted gene modifications in plants. The disclosure also provides methods for use for U6, U3, U2, U5, and 7SL promoters in driving expression of sgRNA polynucleotides which function in a CRISPR/Cas system of targeted gene modification in plants. The disclosure also provides methods of genome modification by insertion of blunt-end DNA fragments at a site of genomic cleavage.

Claims (28)

1. A recombinant DNA construct comprising a U6 snRNA promoter fragment, wherein said U6 snRNA promoter fragment is operably linked to:

(i) a sequence encoding a single-guide RNA (sgRNA); or

(ii) a sequence specifying a non-coding RNA;

and wherein the sequence of said U6 snRNA promoter fragment consists of a sequence selected from the group consisting of SEQ ID NO:7 and SEQ ID NO:8, wherein the U6 snRNA promoter fragment and the sgRNA or the non-coding RNA come from different sources.

2. The recombinant DNA construct of claim 1 , wherein the sequence of said U6 snRNA promoter fragment consists of the sequence of SEQ ID NO:7.

3. The recombinant DNA construct of claim 1 , further comprising a transcription termination sequence.

4. The recombinant DNA construct of claim 1 , further comprising a sequence encoding a promoter operably linked to a sequence encoding a clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas endonuclease gene product.

5. The recombinant DNA construct of claim 4 , wherein the Cas endonuclease gene product is further operably linked to a nuclear localization sequence (NLS).

6. The recombinant DNA construct of claim 4 , wherein the sequence encoding said Cas endonuclease is SEQ ID NO:27, SEQ ID NO:68, SEQ ID NO:97, SEQ ID NO:119, or SEQ ID NO:136.

7. The recombinant DNA construct of claim 1 , wherein the non- coding RNA is a microRNA (miRNA), a miRNA precursor, a small interfering RNA (siRNA), a small RNA (22-26 nt in length) and precursor encoding same, a heterochromatic siRNA (hc-siRNA), a Piwi-interacting RNA (piRNA), a hairpin double strand RNA (hairpin dsRNA), a trans-acting siRNA (ta-siRNA), or a naturally occurring antisense siRNA (nat-siRNA).

8. A cell comprising the recombinant DNA construct of claim 1 .

9. The cell of claim 8 , wherein the cell is a plant cell.

10. A method of introducing a double-strand break in the genome of a cell, comprising introducing in said cell:

a) at least one recombinant DNA construct of claim 1 ; and

b) a second recombinant DNA construct comprising a sequence encoding a promoter operably linked to a sequence encoding a clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas endonuclease gene product operably linked to a nuclear localization sequence (NLS).

11. The method of claim 10 , wherein the U 6 snRNA promoter fragment consists essentially of the sequence of SEQ ID NO:7.

12. The method of claim 10 , wherein the sequence encoding said Cas endonuclease is SEQ ID NO:27, SEQ ID NO:68, SEQ ID NO:97, SEQ ID NO:119, or SEQ ID NO:136.

13. A method of introducing a double-strand break in the genome of a cell, comprising introducing to said cell at least one recombinant DNA construct of claim 4 .

14. The method of claim 13 , wherein the U6 snRNA promoter fragment consists of the sequence of SEQ ID NO:7.

15. The method of claim 13 , wherein the sequence encoding the Cas endonuclease is SEQ ID NO:27, SEQ ID NO:68, SEQ ID NO:97, SEQ ID NO:119, or SEQ ID NO:136.

16. A method of genome modification comprising:

a) introducing a double-strand break in the genome of a plant cell by the method according to claim 10 ; and

b) introducing into said plant cell a recombinant blunt-end double-strand DNA fragment,

wherein said recombinant blunt-end double-strand DNA fragment is incorporated into said double strand break by endogenous DNA repair.

17. A method of genome modification comprising:

a) introducing a double-strand break in the genome of a plant cell by the method according to claim 13 ; and

b) introducing into said plant cell a recombinant blunt-end double-strand DNA fragment,

wherein said recombinant blunt-end double-strand DNA fragment is incorporated into said double strand break by endogenous DNA repair.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2020
From: BROWER-TOLAND, BRENT; KOURANOV, ANDREI Y.; KUEHN, ROSEMARIE; LAWRENCE, RICHARD J.; NAGY, ERVIN D.; RYMARQUIS, LINDA; VEENA, VEENA
To: MONSANTO TECHNOLOGY LLC
Reel/Frame 051919/0977 →
Continuity (2)
Provisional Application 61945700 · Feb 27, 2014
Related Publication 20170166912A1 · Jun 15, 2017